Nutrien Ltd. (NTR.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Nutrien Ltd. (NTR.TO)

103.34

+1.06 (1.04%)

as of Aug 31, 2026, 4:49:33 pm Market Open.

777 watching

Investor Insights

Aug 31, 2026, 12:00 am

This summary was created by AI, based on 23 opinions in the last 12 months.

Experts generally have a favorable outlook on Nutrien Ltd. (NTR-T), citing its strong market position in the fertilizer sector and robust dividend growth, which gives it stability amidst volatility. The company's long-term growth is underpinned by the essential demand for fertilizers, especially as global populations increase. Recent geopolitical tensions have impacted fertilizer pricing, creating both opportunities and challenges for Nutrien, but many analysts see the stock as a solid long-term investment, especially when it dips into the $80s. The consensus suggests that while the stock isn't overly cheap, it presents a reasonable entry point for long-term investors who prioritize quality and potential for appreciation in a cyclical industry. Overall, Nutrien is positioned to benefit from improving farmer balance sheets and lower natural gas prices, making it a compelling option for investors looking for exposure to the agricultural sector.

Consensus

Positive

Valuation

Fair Value

Similar

Covington, COV

DON'T BUY

We had a round trip, going up and down. But AG stocks tend to be weak this time of year. Farmers get their money in the last quarter of the year and don't spend it right now. Once we get past the fourth quarter grain prices get softer. This is not the time.

COMMENT

The leading way way to play phosphates and potash in North America. He likes NTR, but because he's a mid-cap manager (and NTR is large cap) he prefers IFOS-X in this space within this cycle.

COMMENT

NTR or WEF? He would prefer NTR-T as he believes it will eventually be back to making money. He thinks deforestation is one of the biggest contributors to greenhouse gas emissions. There is only so much arable land and thinks NTR-T will benefit the most.

WATCH

It dropped off and came back to $66. The downtrend is probably broken. It will probably go sideways until it breaks through $66 and then go further.

PAST TOP PICK

(A Top Pick Jan 09/18, Up 4%) They merged with Potash a year ago. Well positioned as crop prices have held. The largest potash producer and there is increasing demand for it. Their retail side is around 35% of their operations. Attractive yield of 3.5% and they are doing some share buy backs. Attractive entry point.

TOP PICK

It's a way to get growth that isn't directly tied to the business cycle. They have their own fertilizer cycle. They just sold pieces of other businesses to raise $5 billion cash used to pay down debt. They've raised their dividend and are buying back stock. Pays a 3.5 % dividend. Good entry point now. (Analysts’ price target is $84.29)

TOP PICK

It is the premier agriculture commodity stock in the world. He likes it because the outlook for potash prices is good. They had a poor fall planting in the Midwest in south and the stock came off but he sees a good spring planting so it will be a good time to buy. (Analysts’ price target is $84.20)

PAST TOP PICK

(A Top Pick Nov 30/17, Up 12%) There are $500 million of synergies up for grabs after the big merger, which could even be higher. They are ahead of plan in synergizing. Also are selling $5 billion of non-core assets. This week in Chile, they just sold a lithium mine, generating $4 billion in cash that'll go to share buybacks and dividends. There are big gains still to come.

BUY

It's interesting now. Anytime you see an industry go through a down cycle as long as this, then a merger of two big players, that's usually positive. He likes this long-term, but short-term he expects a recession. He owns a little of this.

TOP PICK

Their Q3 beat by 10% and raised guidance as well as dividend. Well-run. He expects them to deploy $6-8 billion in coming years to drive growth. Will grow earnings 30% annually. Trades at only 13x. Solid dividend and balance sheet. (Analysts’ price target is $84.64)

BUY

They're having an up-and-down year. It's a long-term (5-10-years) play on global fertilizer demand..

BUY

b He bought a few months ago but has very little exposure to commodities. You want to own when base commodities for a company are doing well, which they are. This one is outperforming the Toronto market. It is a good one for an RESP. But keep in mind that these stocks are to be traded.

BUY

It's not far from its book value. Has good potential upside. The risks are reasonable now. He likes it.

TOP PICK

He recently bought it. Stock has fallen 10% in this recession. Expect higher divdends and buybacks to shareholdrs in the coming year. Targets mid-$70's. (3.1% Analysts price target: $82.79)

BUY

Likes it. It's the biggest crop nutriens player in the world, specifically potash and nitrogens, segments which are improving rapidly, and phosphates less so. As a condition of their merger, $5 billion assets were sold and those may be re-deployed into retail network expansion in South America like Brazil, a huge market. There's also $500 million in synergies to be captured which they are doing ahead of schedule. Expect dividend growth, acquisitions and share buybacks.

Showing 331 to 345 of 392 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Kevin Simpson

Capital Wealth Planning

Jim Lebenthal

Cerity Partners

Bill Baruch, Founder, Blue Line Capital

Blue Line Capital

Brianne Gardner

Raymond James

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

Nutrien Ltd. (NTR.TO)